Wellness 360: The clinical practice of UT Health San Antonio’s Nursing School continues to shine

June 6, 2023

Nurse practitioner-led clinics triple patient visits since 2019 Contact: Steven Lee, 210-450-3823, lees22@uthscsa.edu SAN ANTONIO, June 6, 2023 – Wellness 360, a growing patient-care practice of the UT Health San Antonio School of Nursing, quickly has established itself providing primary and acute care to the public at the school’s main campus, at a variety of community […]

Study shows toothpaste with ‘artificial enamel’ ingredient restores enamel, is more effective than fluoride

May 30, 2023

Contact: Steven Lee, 210-450-3823, lees22@uthscsa.edu SAN ANTONIO, May 30, 2023 – An “artificial enamel” ingredient in toothpaste has been shown to help restore enamel in teeth, more effectively relieving sensitivity than fluoride while fighting cavities, according to an internationally published study led by a UT Health San Antonio School of Dentistry professor and researcher. The […]

FDA green-lights bionic pancreas studied at UT Health Science Center, University Health

May 25, 2023

Artificial intelligence insulin delivery and glucose monitoring system cleared for age 6 and older Contact: Will Sansom, UT Health Science Center, 210-567-2579, sansom@uthscsa.edu University Health communications, 210-358-2335 SAN ANTONIO (May 25, 2023) — While it won’t cure children of type 1 diabetes, the “bionic pancreas,” an artificial intelligence-powered system cleared Friday, May 19, by the […]

Mays Cancer Center conducts only clinical trial in America of a specific drug combination for lethal brain cancer glioblastoma

May 23, 2023

An improvement in 6-month progression-free survival warrants additional study in a larger trial, researchers said. Contact: Will Sansom, 210-567-2579, sansom@uthscsa.edu SAN ANTONIO (May 23, 2023) — The Mays Cancer Center at The University of Texas Health Science Center at San Antonio recently conducted a clinical trial combining two drugs in patients with recurrent, high-grade glioblastoma […]

Statement by the Glenn Biggs Institute for Alzheimer’s and Neurodegenerative Diseases about the study drug donanemab

May 22, 2023

Media contact: Will Sansom, 210-567-2579, sansom@uthscsa.edu SAN ANTONIO (May 22, 2023) — Alicia S. Parker, MD, of The University of Texas Health Science Center at San Antonio, is assistant professor of cognitive and behavioral neurology and clinic director for the health science center’s Glenn Biggs Institute for Alzheimer’s and Neurodegenerative Diseases. The Biggs Institute, in […]

Molecule shows potential to combat treatment resistance in brain tumor glioblastoma

May 17, 2023

Glioblastoma-impacted mice lived longer when treated with combination of molecule drug and chemotherapy agent Contact: Will Sansom, 210-567-2579, sansom@uthscsa.edu SAN ANTONIO (May 17, 2023) — Glioblastoma (GBM), a highly devastating brain tumor, has long posed challenges as effective treatments have remained elusive. Despite responding initially to treatment, GBM patients often experience therapy resistance leading to […]